April 14, 2023 - FUS Immuno-Oncology Analysis and more news...

Published: 14 April 2023

April 14, 2023

April is Parkinson’s Awareness Month, and the Foundation is hosting a webinar on new approaches to treat the disease.
Experts will provide an overview of the state of treatment options, including the latest advancements in focused ultrasound.
We encourage patients, healthcare professionals, and researchers to join us Friday, April 21, at 10:00 am Eastern.

Learn More and Register

Foundation Conducts Landscape Analysis of Focused Ultrasound Immuno-Oncology

The focused ultrasound immuno-oncology (FUS-IO) field has grown rapidly in the past decade.
The Foundation team compiled a library of FUS-IO references and assessed where the field stands with respect to six key questions.
The team found that many variables should be considered when predicting treatment response and choosing optimal treatment regimen.

Focused Ultrasound for Epilepsy: Early Pilot Results Published

One-year follow-up results from the first two participants treated in an epilepsy clinical trial have now been published.
Unilateral anterior nucleus thalamus ablation was feasible and significantly reduced or stopped focal seizures.
No serious adverse events were reported, but side effects included memory loss.

Focused Ultrasound Versus Microwave Ablation for Liver Metastases

Researchers conducted a study to compare high-intensity focused ultrasound with microwave ablation for the treatment of small metastatic liver tumors.
The results indicated HIFU was safe and feasible and associated with lower hospitalization costs.

Focused Ultrasound Intellectual Property Update: First Quarter 2023

The Foundation tracks recently issued patents and patent applications filed with the US Patent Office related to the field.
Five new US patents related to focused ultrasound were issued in the first quarter of 2023.

See the List

Forwarded this email by a friend? Sign up to receive these emails here.

“Combining focused ultrasound and immunotherapy is a novel approach that holds immense potential for many difficult-to-treat cancers. Our goal was to assess the data available to help inform future studies.”

‒ Jessica Foley, PhD

Do you have news for our newsletter? Tell us about it!